Chiang‐Shan Niu

452 total citations
23 papers, 375 citations indexed

About

Chiang‐Shan Niu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience. According to data from OpenAlex, Chiang‐Shan Niu has authored 23 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Chiang‐Shan Niu's work include Receptor Mechanisms and Signaling (5 papers), Neuropeptides and Animal Physiology (5 papers) and Diabetes Treatment and Management (4 papers). Chiang‐Shan Niu is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Neuropeptides and Animal Physiology (5 papers) and Diabetes Treatment and Management (4 papers). Chiang‐Shan Niu collaborates with scholars based in Taiwan, Japan and Poland. Chiang‐Shan Niu's co-authors include Ho‐Shan Niu, Juei‐Tang Cheng, Shih‐Hsiang Lo, Chao‐Tien Hsu, Kai‐Chun Cheng, Zhih‐Cherng Chen, Yingxiao Li, Mao‐Tsun Lin, I-Min Liu and Li‐Jen Chen and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Neurochemistry and Nutrients.

In The Last Decade

Chiang‐Shan Niu

23 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiang‐Shan Niu Taiwan 13 176 73 63 56 49 23 375
Min-You Qi China 10 227 1.3× 113 1.5× 97 1.5× 43 0.8× 50 1.0× 20 505
Yanming He China 15 229 1.3× 61 0.8× 68 1.1× 100 1.8× 82 1.7× 40 521
Mohammad Dallak Saudi Arabia 15 131 0.7× 75 1.0× 97 1.5× 78 1.4× 39 0.8× 43 591
Ho‐Shan Niu Taiwan 14 291 1.7× 100 1.4× 99 1.6× 57 1.0× 67 1.4× 32 557
Aixin Shi China 11 220 1.3× 74 1.0× 56 0.9× 38 0.7× 48 1.0× 23 479
You Mee Ahn South Korea 11 133 0.8× 81 1.1× 69 1.1× 49 0.9× 47 1.0× 33 339
Amir M. Al Hroob Jordan 9 150 0.9× 90 1.2× 111 1.8× 40 0.7× 36 0.7× 12 479
Kirtikar Shukla United States 16 211 1.2× 32 0.4× 98 1.6× 70 1.3× 59 1.2× 29 570
Qi Bao China 9 159 0.9× 50 0.7× 44 0.7× 48 0.9× 84 1.7× 17 370
Phatchawan Arjinajarn Thailand 10 94 0.5× 96 1.3× 50 0.8× 44 0.8× 34 0.7× 15 411

Countries citing papers authored by Chiang‐Shan Niu

Since Specialization
Citations

This map shows the geographic impact of Chiang‐Shan Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiang‐Shan Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiang‐Shan Niu more than expected).

Fields of papers citing papers by Chiang‐Shan Niu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiang‐Shan Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiang‐Shan Niu. The network helps show where Chiang‐Shan Niu may publish in the future.

Co-authorship network of co-authors of Chiang‐Shan Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Chiang‐Shan Niu. A scholar is included among the top collaborators of Chiang‐Shan Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiang‐Shan Niu. Chiang‐Shan Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niu, Chiang‐Shan, et al.. (2020). Comparison of area under the curve in various models of diabetic rats receiving chronic medication. Archives of Medical Science. 18(4). 1078–1087. 12 indexed citations
2.
Lo, Shih‐Hsiang, Chao‐Tien Hsu, Ho‐Shan Niu, et al.. (2017). Cryptotanshinone Inhibits STAT3 Signaling to Alleviate Cardiac Fibrosis in Type 1-like Diabetic Rats. Phytotherapy Research. 31(4). 638–646. 40 indexed citations
3.
Wang, Lin‐Yu, Kai‐Chun Cheng, Yingxiao Li, et al.. (2017). Glycyrrhizic acid increases glucagon like peptide-1 secretion via TGR5 activation in type 1-like diabetic rats. Biomedicine & Pharmacotherapy. 95. 599–604. 30 indexed citations
4.
Lo, Shih‐Hsiang, Yingxiao Li, Kai‐Chun Cheng, et al.. (2017). Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 390(11). 1097–1104. 24 indexed citations
5.
Kuo, Shu‐Chun, Yingxiao Li, Kai‐Chun Cheng, et al.. (2017). Increase in renal erythropoietin receptors in diabetic rats is mainly mediated by hyperglycemia associated with the STAT3/GATA-1 signaling pathway. Biomedicine & Pharmacotherapy. 96. 1094–1102. 6 indexed citations
6.
Lo, Shih‐Hsiang, et al.. (2017). Loperamide-induced Cardiac Depression Is Enhanced by Hyperglycemia: Evidence Relevant to Loperamide Abuse. Archives of Medical Research. 48(1). 64–72. 2 indexed citations
7.
Li, Yingxiao, Kai‐Chun Cheng, Chiang‐Shan Niu, et al.. (2017). Investigation of triamterene as an inhibitor of the TGR5 receptor: identification in cells and animals. Drug Design Development and Therapy. Volume11. 1127–1134. 25 indexed citations
8.
Kuo, Shu‐Chun, Yingxiao Li, Kai‐Chun Cheng, et al.. (2017). Investigation of the pronounced erythropoietin-induced reduction in hyperglycemia in type 1-like diabetic rats. Endocrine Journal. 65(2). 181–191. 6 indexed citations
9.
Cheng, Juei‐Tang, et al.. (2016). Eucommia bark (Du-Zhong) improves diabetic nephropathy without altering blood glucose in type 1-like diabetic rats. Drug Design Development and Therapy. 10. 971–971. 24 indexed citations
10.
Cheng, Juei-Tang, et al.. (2016). Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats. Drug Design Development and Therapy. 10. 1877–1877. 13 indexed citations
11.
Niu, Ho‐Shan, et al.. (2016). Amarogentin ameliorates diabetic disorders in animal models. Naunyn-Schmiedeberg s Archives of Pharmacology. 389(11). 1215–1223. 17 indexed citations
12.
Cheng, Juei‐Tang, et al.. (2015). Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals. Drug Design Development and Therapy. 9. 5625–5625. 5 indexed citations
13.
Niu, Chiang‐Shan, Li‐Jen Chen, & Ho‐Shan Niu. (2014). Antihyperglycemic action of rhodiola-aqeous extract in type1-like diabetic rats. BMC Complementary and Alternative Medicine. 14(1). 20–20. 27 indexed citations
14.
Niu, Ko‐Chi, et al.. (2012). Attenuating brain inflammation, ischemia, and oxidative damage by hyperbaric oxygen in diabetic rats after heat stroke. Journal of the Formosan Medical Association. 112(8). 454–462. 20 indexed citations
15.
Niu, Chiang‐Shan, Mao‐Tsun Lin, I-Min Liu, & Juei‐Tang Cheng. (2003). Role of striatal glutamate in heatstroke-induced damage in streptozotocin-induced diabetic rats. Neuroscience Letters. 348(2). 77–80. 20 indexed citations
16.
Niu, Chiang‐Shan, et al.. (1998). Modification of superoxide dismutase (SOD) mRNA and activity by a transient hypoxic stress in cultured glial cells. Neuroscience Letters. 251(3). 145–148. 10 indexed citations
17.
Tsai, Yu‐Chuan, et al.. (1996). Inhibitory effect of propofol on sympathetic neurotransmission results in changes of plasma neuropeptide Y in rats. Journal of Autonomic Pharmacology. 16(1). 29–33. 4 indexed citations
18.
Niu, Chiang‐Shan, et al.. (1996). Changes of Neuropeptide Y Messenger RNA and Peptide by Drugs Influencing Endogenous Norepinephrine Content in Cerebrocortex of the Rat. Journal of Neurochemistry. 66(5). 2100–2104. 6 indexed citations
19.
Chu, L.W., Feng‐Lin Hsu, Fu‐Yu Chueh, Chiang‐Shan Niu, & Juei‐Tang Cheng. (1996). Antihypertensive Activity of dl‐Tetrahydropalmatine, an Active Alkaloid Isolated from the Tubers of Corydalis racemosa. Journal of the Chinese Chemical Society. 43(6). 489–492. 3 indexed citations
20.
Niu, Chiang‐Shan, et al.. (1996). Activation of α1-adrenoceptors to lower cerebrocortical neuropeptide Y (NPY)-like immunoreactivity in rats receiving pargyline treatment. Neuroscience Letters. 218(3). 161–164. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min-You Qi Breakdown of academic impact, for papers by Yanming He Breakdown of academic impact, for papers by Mohammad Dallak Breakdown of academic impact, for papers by Ho‐Shan Niu Breakdown of academic impact, for papers by Aixin Shi Breakdown of academic impact, for papers by You Mee Ahn Breakdown of academic impact, for papers by Amir M. Al Hroob Breakdown of academic impact, for papers by Kirtikar Shukla Breakdown of academic impact, for papers by Qi Bao Breakdown of academic impact, for papers by Phatchawan Arjinajarn
Rankless by CCL
2026